While reviewing advanced gynecological cancer care in Mumbai, I found that one of the most important conversations around advanced ovarian cancer is about removing as much visible disease as safely possible. ovarian cancer debulking surgery is a major procedure used in selected patients when ovarian cancer has spread beyond the ovary. The objective is to achieve optimal cytoreduction, meaning that the surgeon removes as much cancerous tissue as possible before or alongside further cancer treatment. At Kirit Nursing Home, Dr. Maitreyee Parulekar brings specialized training in gynecological oncology, minimally invasive surgery and robotic surgery to the management of complex gynecological conditions.
What Is Ovarian Cancer Debulking Surgery?
Debulking, also called cytoreductive surgery, is an important component of ovarian cancer debulking surgery and aims to remove visible cancer deposits from the abdomen and pelvis. Advanced ovarian cancer may spread to structures such as the uterus, omentum or peritoneum. Depending on the extent of disease, surgery can therefore involve more than removing the ovaries and may require removal of other affected tissues or organs.
The central objective is to leave as little visible cancer as safely possible. The reference information notes that optimal cytoreduction, particularly when very little residual disease remains, can improve the effectiveness of chemotherapy administered after surgery.
However, not every patient follows the same surgical pathway. The decision depends on the extent of cancer, the patient’s general health, imaging findings and whether complete or near-complete cytoreduction appears achievable.
When Is Debulking Recommended?
Advanced ovarian cancer can present differently from patient to patient. Some women may have abdominal bloating, pelvic discomfort, changes in bowel habits, reduced appetite or other nonspecific symptoms. Once ovarian cancer has been diagnosed, imaging and other investigations help the cancer team determine its stage and distribution.
In some patients, surgery may be performed first. This is known as primary debulking surgery. In other situations, doctors may recommend chemotherapy before surgery, known as neoadjuvant chemotherapy. This approach can help reduce the extent of disease before an operation.
The choice between surgery first and chemotherapy first is individualized. According to Dr. Maitreyee Parulekar’s clinical information, scans, blood investigations and assessment by an experienced surgical team help guide this decision.
What Happens During the Procedure?
The exact operation varies according to where the cancer has spread. The surgeon evaluates the abdominal and pelvic cavity and removes visible cancerous deposits wherever safely possible.
In more extensive cases, surgery may involve procedures affecting nearby structures. The reference material explains that bowel resection or bladder repair may sometimes be required when cancer has involved these organs. The priority remains achieving effective cancer removal while maintaining patient safety.
The procedure is performed under general anesthesia. The reference page states that the operation commonly takes approximately three to six hours, although the duration can vary considerably depending on the extent of disease and complexity of surgery. Hospital recovery is also individualized, with the referenced information indicating that many patients may remain hospitalized for around three to seven days.
Recovery and Chemotherapy After Surgery
Recovery after major cancer surgery requires patience and close medical monitoring. Temporary fatigue, abdominal discomfort, bloating, constipation, reduced appetite, sleep difficulties and emotional changes can occur during recovery. Infection, bleeding, scarring and complications involving nearby organs are also potential surgical risks.
The timing of additional treatment depends on healing and the patient’s overall condition. The reference page states that chemotherapy may commonly begin around three to six weeks after surgery, following assessment of recovery and relevant blood tests.
Patients should therefore follow their surgical and oncology team’s instructions regarding wound care, medication, nutrition, activity and follow-up appointments.
Understanding the Benefits and Risks
The principal benefit of cytoreductive surgery is reducing the amount of visible cancer in the body. When appropriate cytoreduction can be achieved, subsequent chemotherapy may work more effectively against remaining microscopic disease.
At the same time, this is a major operation and should not be considered risk-free. Possible complications include bleeding, infection, abdominal pain, bowel-related problems and injury to nearby organs. Some patients may require additional procedures if cancer has spread to surrounding structures.
The potential benefits and risks must therefore be discussed individually. A patient’s age, general health, cancer stage, distribution of disease and ability to tolerate extensive surgery all contribute to treatment planning.
Dr. Maitreyee Parulekar’s Qualifications and Expertise
Dr. Maitreyee Parulekar is a gynecological surgeon with qualifications including MBBS, MS OBGY from KEM, MRCOG (UK) and FMAS (MUHS). She completed her Master’s training in Obstetrics and Gynaecology at Seth G.S. Medical College and KEM Hospital, Mumbai, where she secured a University Gold Medal.
Her advanced professional training includes a Fellowship in Gynaecological Oncosurgery and Robotic Surgery at Seoul National University Hospital, South Korea. She has also been a Visiting Scholar in Minimally Invasive Gynecology at Mount Sinai Hospital and Women’s College Hospital in Toronto and completed fellowship training in minimally invasive gynecology and gynecological oncology at Galaxy Care Laparoscopy Institute, Pune.
Her clinical expertise encompasses gynecological oncology, advanced laparoscopic procedures, robotic surgery and minimally invasive treatment for benign and malignant gynecological conditions. Her academic profile also includes research and publications in national and international peer-reviewed journals, with research interests involving minimally invasive techniques, surgical outcomes and gynecological cancers.
These qualifications are particularly relevant when complex cancer surgery requires careful assessment of the disease and a multidisciplinary approach.
Care at Kirit Nursing Home
Kirit Nursing Home is among Dr. Maitreyee Parulekar’s listed practicing locations in Mumbai. Her practice also extends to several hospitals, including Gleneagles Hospital, Parel, Nalini Speciality Hospital, AllCure SuperSpeciality Hospital, Criticare Hospital, Andheri, and Surya Hospitals, Santacruz.
For patients looking for a Gynecologist In Vile Parle, Mumbai, Kirit Nursing Home provides an accessible location for consultation with Dr. Maitreyee Parulekar Her broader clinical practice in gynecological oncology and minimally invasive surgery allows patients with complex conditions to discuss diagnosis, treatment options and surgical planning with a specialist.
Why Specialist Surgical Planning Matters
Cancer surgery is not simply about removing a tumor. In advanced ovarian cancer, the distribution of disease can determine whether surgery is appropriate, how extensive it needs to be and whether chemotherapy should be administered before or after the operation.
Dr. Maitreyee Parulekar‘s background as a Top Gynae Oncologist In Mumbai, combined with specialized training in gynecological oncology, robotic surgery and minimally invasive gynecology, provides a clinical foundation for managing complex gynecological cancers. Her profile also highlights patient-centered care and the use of advanced surgical techniques where appropriate.
Consultation With Dr. Maitreyee Parulekar
If you or a family member has been diagnosed with ovarian cancer and surgery has been recommended, an individualized consultation can help clarify the stage of disease, surgical objectives, possible risks and the expected treatment pathway.
📞 +91 72087 27500 | +91 97023 58222
📧 info@drmaitreyeegynec.in
Get Directions to the Clinic – Kirit Nursing Home, Vile Parle
Discussing the diagnosis with a gynecological oncology specialist can help patients and families understand their available treatment options and prepare for the next stage of care.
Frequently Asked Questions
1. What is the main goal of debulking surgery for ovarian cancer?
The main goal is to remove as much visible ovarian cancer as safely possible. Achieving optimal cytoreduction can help improve the effectiveness of subsequent chemotherapy in appropriate patients.
2. How long does ovarian cancer debulking surgery take?
The duration varies according to the extent and location of cancer. The reference information states that the procedure may take approximately three to six hours, although complex cases can require more or less time.
3. Is chemotherapy required after surgery?
Chemotherapy is commonly an important part of treatment for advanced ovarian cancer, but the exact treatment plan depends on the cancer type, stage, surgical findings and the patient’s overall health. The treating oncology team determines the appropriate sequence and timing.
4. What are the possible side effects after debulking surgery?
Recovery can involve fatigue, abdominal discomfort, bloating, constipation, appetite changes and temporary emotional or sleep-related difficulties. Major surgery can also carry risks such as infection, bleeding and injury to nearby organs.